Explore more publications!

Trump Launches Federal Website Promising “World’s Lowest” Drug Prices

(MENAFN) US President Donald Trump announced on Thursday the introduction of a federal website aimed at making prescription medications more affordable, promising Americans “the world’s lowest prices.”

Speaking at the White House, Trump said that starting Thursday, dozens of widely used prescription drugs would be offered at “dramatic discounts” through TrumpRx.gov.

The initiative adopts a “most-favored-nation” pricing model, ensuring that the US pays no more than the lowest price charged for the same drug in any other country. “We’re taking the lowest price paid for drugs, and we will pay equal to whatever the lowest price anywhere in the world,” Trump said, describing the plan as a “tremendous reduction” for consumers.

He noted that the pricing strategy may push up costs in other countries, adding, “Drug prices in other nations will go up by doing this, they had to agree. And the reason they agreed is I used tariffs. I said, ‘If you don't put them up, then we're going to put tariffs on your nation, which will be more expensive to you.’”

Trump specifically highlighted steep price reductions for popular weight-loss medications known as GLP-1 drugs, citing Novo Nordisk’s Ozempic as an example.

Dr. Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services (CMS), also addressed the event, emphasizing that the program aims to shield vulnerable Americans from unaffordable prescription costs.

MENAFN07022026000045017640ID1110708238


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions